Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Filgotinib is approved by the EMA for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have had an inadequate response to, or are intolerant to, one or more disease-modifying antirheumatic drugs (DMARDs). However, Filgotinib does not have FDA approval for the treatment of RA in the United States, as the FDA requested additional safety data - particularly regarding reproductive toxicity and sperm parameters - before granting marketing approval, which led to a delayed and ultimately not granted appro…